Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HIV: Cell Binding and Entry
Craig B. Wilen, John C. Tilton, Robert W. Doms
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 8, pp. a006866-a006866
Open Access | Times Cited: 569

Showing 1-25 of 569 citing articles:

HIV-1 Antiretroviral Drug Therapy
Eric J. Arts, Daria J. Hazuda
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 4, pp. a007161-a007161
Open Access | Times Cited: 790
HIV-1 Reverse Transcription
Wei-Shau Hu, S H Hughes
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 10, pp. a006882-a006882
Open Access | Times Cited: 427
Fusion of Enveloped Viruses in Endosomes
Judith M. White, Gary R. Whittaker
Traffic (2016) Vol. 17, Iss. 6, pp. 593-614
Open Access | Times Cited: 360
Virus–Receptor Interactions: The Key to Cellular Invasion
Melissa S. Maginnis
Journal of Molecular Biology (2018) Vol. 430, Iss. 17, pp. 2590-2611
Open Access | Times Cited: 328
Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells
Aleksandra Milewska, Mirosław Zarębski, Paulina Nowak, et al.
Journal of Virology (2014) Vol. 88, Iss. 22, pp. 13221-13230
Open Access | Times Cited: 299
HIV Transmission
George M. Shaw, Eric Hunter
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 11, pp. a006965-a006965
Open Access | Times Cited: 274
Wuhan to World: The COVID-19 Pandemic
Ashok Kumar, Rita Gill Singh, Jaskaran Kaur, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 202
Antiviral surfaces and coatings and their mechanisms of action
Paulina D. Rakowska, Mariavitalia Tiddia, Nilofar Faruqui, et al.
Communications Materials (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 202
Maraviroc: a review of its use in HIV infection and beyond
Georgette D. Kanmogne, Shawna M. Woollard
Drug Design Development and Therapy (2015), pp. 5447-5447
Open Access | Times Cited: 190
Rapid manufacturing of non-activated potent CAR T cells
Saba Ghassemi, Joseph S. Durgin, Selene Nuñez-Cruz, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 2, pp. 118-128
Open Access | Times Cited: 188
Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives
Sulong Xiao, Zhenyu Tian, Yufei Wang, et al.
Medicinal Research Reviews (2018) Vol. 38, Iss. 3, pp. 951-976
Open Access | Times Cited: 187
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
Lukas Pawig, Christina Klasen, Christian Weber, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 178
Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses
Yue Ma, Estrella Frutos-Beltrán, Dongwei Kang, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 7, pp. 4514-4540
Open Access | Times Cited: 134
Molecular basis of human immunodeficiency virus type 1 drug resistance: Overview and recent developments
Luis Menéndez‐Arias
Antiviral Research (2013) Vol. 98, Iss. 1, pp. 93-120
Closed Access | Times Cited: 198
Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide
Huan Yan, Xiaozhong Peng, Wenhui He, et al.
Journal of Virology (2013) Vol. 87, Iss. 14, pp. 7977-7991
Open Access | Times Cited: 181
HIV-1 target cells in the CNS
Sarah Joseph, Kathryn T. Arrildt, Christa Buckheit Sturdevant, et al.
Journal of NeuroVirology (2014) Vol. 21, Iss. 3, pp. 276-289
Open Access | Times Cited: 171
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
Toshana L. Foster, Harry Wilson, Shilpa S. Iyer, et al.
Cell Host & Microbe (2016) Vol. 20, Iss. 4, pp. 429-442
Open Access | Times Cited: 166
Line tension at lipid phase boundaries as driving force for HIV fusion peptide-mediated fusion
Sung‐Tae Yang, Volker Kiessling, Lukas K. Tamm
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 151
Synthetic Peptides as Protein Mimics
Andrea M. Gross, Chie Hashimoto, Heinrich Sticht, et al.
Frontiers in Bioengineering and Biotechnology (2016) Vol. 3
Open Access | Times Cited: 144
Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine
Elena Zaitseva, Eugene Zaitsev, Kamran Melikov, et al.
Cell Host & Microbe (2017) Vol. 22, Iss. 1, pp. 99-110.e7
Open Access | Times Cited: 125
Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives
Shubhadeep Roychoudhury, Anandan Das, Pallav Sengupta, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 24, pp. 9411-9411
Open Access | Times Cited: 124
Glycan–protein interactions in viral pathogenesis
Rahul Raman, Kannan Tharakaraman, V. Sasisekharan, et al.
Current Opinion in Structural Biology (2016) Vol. 40, pp. 153-162
Open Access | Times Cited: 122
HIV-1 Pathogenesis: The Virus
R. Swanstrom, John M. Coffin
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 12, pp. a007443-a007443
Open Access | Times Cited: 121
HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
Tram N. Q. Pham, Sabelo Lukhele, Fadi Hajjar, et al.
Retrovirology (2014) Vol. 11, Iss. 1
Open Access | Times Cited: 116
Page 1 - Next Page

Scroll to top